MTA1 and neoplasm: These compounds appear to regulate the PTEN/AKT and P53 signaling pathways through the inhibition of the MTA1/HDAC unit of the NuRD complex in cancer cells and finally inhibit tumor growth, progression, and metastasis of cancers.